Abstract Ex vivo production of highly stimulator mature dendritic cells (DCs) for cellular therapy has been used to treat diVerent pathological conditions with the aim of inducing a speciWc immune response. In the last decade, several protocols have been developed to mature monocyte-derived DCs: each one has led to the generation of DCs showing diVerent phenotypes and stimulatory abilities, but it is not yet known which one is the best for inducing eVective immune responses. We grouped several diVerent maturation protocols according to the downstream pathways they activated and reviewed the shared features at a transcriptomic level to reveal the potential of DCs matured by each protocol to develop Th-polarized immune responses.
Immunotherapy and dendritic cells
Dendritic cells (DCs) are considered essential for the initiation, programming, and regulation of antigen-speciWc immune responses [1] . They play a fundamental role in supporting the survival and the eVector function of primed T cells while coordinating communication among cells of the immune system. The observation that patients with cancer have DCs that exhibit a reduced ability to activate Th1-polarized immune responses [2, 3] makes the understanding of DC maturation a prerequisite for the design of rational immunotherapies based on antigen-speciWc reactivation of adaptive immune responses. Since DCs were Wrst generated ex vivo from monocytes for immunotherapy [4] and used in clinical trials [5, 6] , they have been found to be eVective in treating patients with lymphoma, melanoma, and renal cell carcinoma [7, 8] , although their potential utilization is wider and goes beyond cancer therapy. However, the clinical response rates of DC therapies are only 10-15% [7, 9] . Various reasons for the limited eYcacy of monocytederived DC-based vaccines have been hypothesized, with ineYcient activation of Th1-polarized responses due to incomplete DC maturation being the most cited [7, 10, 11] .
T-cell activation by DCs relies on three diVerent signals [7, 8] : antigen presentation, co-stimulatory, and polarizing. The Wrst two signals are intrinsic to mature DCs. During maturation, in fact, the antigen processing ability of DCs decreases while their antigen presentation and expression of co-stimulatory molecules increase. For example, the expression of the B7 family of co-stimulator molecules is increased in mature DCs [12] . Optimizing the expression of polarizing molecules is complicated: DCs can secrete diVerent cytokines, growth factors, and chemokines that can, in turn, attract diVerent immune cells and diVerentially inXuence their activation in situ [13] [14] [15] . Moreover, the methods that are currently used to produce DCs for adoptive immune therapy may not be optimized: immune responses against tumors, pathogens, and autoimmunities need diVerent Th-speciWc polarization [16] . For these reasons, Th-speciWc immune responses should be obtained by stimulating DCs to produce cells with a speciWc Th polarizing ability; however, DC-induced Th polarization is still not well understood or characterized [16] .
Over the last decade, a large body of information has accumulated concerning the functional properties of DCs generated ex vivo under diVerent conditions [8] . However, the molecular determinants that regulate eVective immune responses are still poorly deWned [7] . Moreover, the heterogeneity of the clinical trials done so far makes it impossible to deWne the most eYcient protocol according to clinical results [9] . DNA microarray technology has often been used to study the maturation of DCs, but only a small number of studies have systematically compared diVerent conditions of maturation [14, 15] . This review summarizes the salient results from these studies following a pathway-associated principle and clustered the diVerent maturation strategies according to conceptually convergent theorems with the aim of suggesting future studies and directions to improve the eVectiveness of DC-based immunotherapy.
We Wrst selected publications on PubMed using the following sequence of terms: "Monocyte" "Dendritic Cells" "Human" "Gene ProWling". Then, we selected only those published between September 2000 and June 2009 that focused on DCs production for immunotherapy and that included a protocol for generating mature DCs. The compounds used for the maturation of DCs were clustered according to the overlapping downstream signaling pathways that they activated. By using this method, a less complex and sharper description of the maturation of DCs resulted. All the pathways used for this analysis were canonical pathways described by Ingenuity Pathways Analysis (Ingenuity ® Systems, www.ingenuity.com, Mountain View, CA). To restrict the analyses to more reliable and consistent data, genes were selected as induced only when cited by at least two papers. The only exception was when only one paper described the transcription proWling of a speciWc maturation protocol [17] . Considering that the experiments used diVerent microarray platforms and designs, we did not include any fold-change or p-value criteria for the selection of the genes, but trusted the methods used by the authors to deWne a gene as induced.
DiVerent protocols for DC maturation
Eighteen reports Wt the criteria for this study (Table 1 ). All reports were based on studies using monocyte-derived DCs. Generally, peripheral blood mononuclear cells (PBMCs) were collected by apheresis, and monocytes were obtained by elutriation, CD14 antibody selection, or selection of adherent cells after overnight culture on plates. Protocols to generate immature DCs from circulating monocytes most frequently used granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4), although the concentrations of these factors and time in culture varied among studies. One study used interferon-(IFN-) instead of IL-4 during the diVerentiation step [18] . Then, because of the low T-cell activation potential of the resulting immature DCs, cells were matured with immune response activation stimuli. Several strategies have been used to produce mature DCs, which are characterized by high immune cell activation potential. Factors used to mature immature DCs included lipopolysaccharide (LPS), CD40 ligand (CD40L), tumor necrosis factor-(TNF-), IFN-, and IFN-. Cocktails combining several factors to better recreate the inXammation environment have also been used. Factors used in maturation cocktails include prostaglandin E2 (PGE2), interleukin-1 (IL-1 ), IL-6, and polyinosinic: polycytidylic acid (poly (I:C)).
Based on the level of overlap of canonical pathways believed to be primarily activated by each compound (Fig. 1) , we clustered various maturation protocols into three major categories: LPS, CD40L/TNF-, and IFNdependent maturation strategies. In addition, a fourth category was needed for protocols that included cocktails of factors that represented a combination of the other categories. For instance, LPS interacts with toll-like receptors (TLR)-4 leading to the activation of diVerent transcription factors including nuclear factor-kB (NF-kB), p38 mitogenactivated protein kinase (p38 MAPK), c-Jun N-terminal kinase (JNK), and extra-cellular signal-regulated protein kinase (ERK1/2). On the other hand, although both CD40L and TNF-activate NF-kB, this activation occurs through diVerent and only partially overlapping signaling cascades. In contrast, IFN-and IFN-signal through the Janus kinase (JNK) and tyrosine kinase (TYK) cascade leading to the activation of signal transducer and activator of transcription proteins (STATs), which leads to down-stream eVects where the action of NF-kB is also complemented by the action of several interferon regulatory factors (IRFs). We summarized the eVects of the diVerent maturation protocols on the transcriptional proWles of DCs according to these broad categories. It should be kept in mind that this report is obviously limited by the protocols used for DC activation, which generally refer to a speciWc time point after the maturation process is started.
Regarding the diVerent monocyte puriWcation methods, there are no speciWc studies aimed at identifying the eVects of the puriWcation method on the Wnal product at the transcriptomic level. Dohnal showed that the greatest diVerences due to the puriWcation method were on the purity and yield of the starting monocytes, but functionally no statistical diVerences were noticed [19] . In addition, the high degree of similarity of the phenotypic characteristics of the DCs derived from diVerent monocyte selection techniques [14, [20] [21] [22] [23] , as well as the observation that the monocyte-derived DCs do not show diVerences at a transcriptomic level due to diVerences in processing [24] , suggests that the puriWcation method has only minor eVects on the Wnal product. Thus, it is possible that other information could have been gathered if analyses were performed at diVerent time points as was clearly shown by Piqueras [25] .
LPS
Because of its bacterial origin and its predominant role as a pathogen-associated pattern (PAP), LPS represents a prototypical model of DC maturation. Gene proWling studies (see Table 1 ) have shown that several chemokine genes are induced by LPS: CCL5 (RANTES), CCL4 (MIP-1 ), CCL20, CCL18 (DC-CK1), CCL19 (MIP-3 ), and CCL23 (MPIF-1) [20, 22, 23, 26, 27] . The expression of CCL5, CCL4, CCL20, and CCL18 has also been conWrmed by RT-PCR, ELISA, or protein array [28] [29] [30] [31] . CCL5 primarily mediates the traYcking and homing of classical LPS (100 ng/ml) n/a microarray (AVymetrix) [14] LPS (1 g/ml) 16 h microarray (in house) [20] LPS (100 ng/ml) 2 days microarray (Gearray) [84] CD40L (undeWned) 2 days microarray (AVymetrix) [46] CD40L (undeWned) n/a microarray (AVymetrix) [14] CD40L (1 g/ml) 1 day subtractive hybridization [47] TNF-(50 ng/ml) 2 days microarray (Clontech) [48] TNF-(10 ng/ml) 7 days microarray (HuGeneFL) arrays (AVymetrix) [49] TNF-(10 ng/ml) 1 days microarray (AVymetrix) [85] TNF-(1,000 U/ml) 2 days microarray (AVymetrix) [18] TNF-(5 ng/ml) 1 day DD-PCR [23] IFN (1,000 U/ml) 8 h microarray (in house) [86] IFN-(1,000 U/ml) 2 days microarray (Clontech) [87] IL-1 (1,870 U/ml), 3 days microarray (Genome Systems) [88] IL-6 (1,000 U/ml), TNF-(1,100 U/ml),
IL-1 (10 ng/ml), 2 days microarray (AVymetrix) [15] IL-6 (1,000 IU/ml), TNF (10 ng/ml),
IL-1 (25 ng/ml), 2 days microarray (AVymetrix) [15] IFN-(3,000 IU/ml), IFN-(1,000 IU/ml), TNF-(50 ng/ml), poly (I:C) (20 ng/ml) IL-1 (10 ng/ml), n/a microarray (AVymetrix) [14] IL-6 (1,000 U/ml), TNF-(10 ng/ml), PGE2 (1 m/ml) LPS (100 mg/ml), 1 day microarray (in house) [17] IFN-(1,000 IU/ml) [32] . Increased CCL5 expression has been associated with a wide range of inXammatory disorders and pathologies. It is thought to act by promoting leukocyte inWltration to sites of inXammation [33] . CCL4 has both chemotactic and pro-inXammatory eVects, attracting, in particular, monocytes to the site of inXammation [34] . CCL20 interacts with CCR-6 and recruits immature DCs, their precursors, and NKT cells [35] . Both CCL18 and CCL23 can attract lymphocytes, immature DC, and monocytes. It remains unclear whether CCL18 predominantly favors pro-inXammatory (Th1 or Th2) or anti-inXammatory/tolerogenic responses depending upon the microenvironment in which it is secreted [36] . Another transcript that was often observed to be induced by LPS-matured DCs is the BCL-related protein A1 (BCL2A1), which, like BCL-2, has anti-apoptotic function and whose induction has been conWrmed by ribonuclease protection assay [37] . It promotes the survival of immune cells and consequently leads to stronger immune responses [36] . Taken together, these data suggest that after DCs detect pathogens, they produce factors to enhance the recruitment of diVerent immune system cells, and consequently, activate the primary immune response against pathogens in the area of infection.
Other genes whose expression has often been found to be enhanced in DCs matured with LPS are DUSP-5, DUSP-1, and TNFAIP3. The increased expression of these latter two has been conWrmed at protein level [38, 39] . These three genes play an important role in inhibiting MAPK activity and in particular the activity of NF-kB, JNK, and ERK2 [40] , indicating that the activation signal induced by LPS has a self-regulatory loop that dampens its eVects over time.
Other genes whose expression is increased are super-oxide dismutase 2 (SOD2) and ICAM1 (CD54) and whose induction has been conWrmed at a protein level [41] [42] [43] . Both genes have a putative role in inXammation. The adhesive molecule ICAM1 is directly implicated in leukocyte adhesion and transmigration during inXammation [44] . SOD2, instead, is primarily involved in the catabolism of reactive oxygen species usually generated during inXammation [45] .
TNF-/CD40L
According to our selection criteria, TNF-/CD40L induces the expression of a pattern of genes tightly associated with TNF family signaling: CCL17 (TARC), IL-10R, IL-13R, MYO1A, and GM-CSFR [14, 18, 23, [46] [47] [48] [49] [50] . CCL17, IL-10R, and Il-13R have been observed to be induced by TNF-/CD40L also with other techniques [46, 51] . CCL17 is a chemokine that is able to recruit memory DCs, CD4
+ cells, and Th2-T cells. High levels of CCL17 in serum are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy [52] . Both IL-10R and IL-13R are cytokines receptors involved in Th2 cell diVerentiation [53] ; both receptors can also make DCs more responsive to the Th2-cytokine imbalance that has been observed in several tumor microenvironments [54] , and thus in this way weakening the immunogenic properties of DCs. The transcription proWle of DCs matured with TNF-/CD40L suggests that these DCs polarize T cells toward a Th2 response. This observation perfectly correlates with the impaired ability of TNF--matured DCs to induce the Th1 immune response described by Decker [54] . In fact, TNF--matured DCs show a lack of secretion of IL-12 and IFN-and consequentially a reduced ability to activate cytotoxic T-cell responses in vitro [54] .
IFNs
Due to the central role played by IFNs in the initiation of innate and adaptive immune responses, the eVects on maturation of DCs by type I (IFN-) and type II (IFN-) IFNs have been widely studied [55, 56] . Although the physiological role of IFNs in DC function in vivo is still not clear, it has been reported that in vitro IFN-induces the diVerentiation and maturation of DCs and IFN-can be used alone or in combination with other compounds to mature DCs, leading to the secretion of large quantities of IL-12 [18, [57] [58] [59] . Moreover, type I IFNs enhance the maturation of DCs through a positive feedback loop, acting as autocrine mediators either when used alone or in combination with other factors [58, 60, 61] . Gene proWling studies indicate that the early response (6-8 h following stimulation) of DCs to IFN stimulation includes the expression of well-described IFNstimulated genes (ISGs), such as the CXCR3 ligand chemokines CXCL-9/MIG, CXCL-10/IP-10, CXCL-11/I-TAC, MXa, and ISG-15 [62] . Furthermore, both type I and type II IFNs stimulate, though with diVerent intensities, the STAT-1/IRF-1/IL-15 axis which has recently been shown to play a key role in immune-mediated tissue rejection [63, 64] . In general, it has been concluded that IFN-based maturation of DCs is strongly biased toward a Th1 immune response. This observation is also suggested by a study of Longhi et al., where the induction of Th1 immune response has been shown to require type I IFNs [65] .
Since IFN-dependent signaling is time and cell type dependent [66] , it is important to keep in mind that diVerent methods and/or stimulation of diVerent cell types will yield diVerent results. For instance, type I IFNs induce phosphorylation of STAT1 or STAT4 in immature DCs and mature DCs, respectively [67] . These diVerences are, however, likely to be quantitative in most cases rather than qualitative and the large majority of ISGs induced by either type of IFNs will likely separate the transcriptional patterns of DCs induced by IFNs from those of all other methods of maturation. In fact, IFN-induces a pattern of expression that is similar to the majority of the ISGs in both immature and mature DCs [67] . Obviously, since stimulation of several TLRs (i.e. TLR-7, -8 and -9) is tightly linked to the secretion of IFNs and activation of IRFs, it is likely that maturation protocols involving nucleic acid containing PAPs of damage-associated patterns (DAPs) may lead to the activation of similar pathways and produce similar Th1 polarization.
Maturation cocktails
In an attempt to recreate a physiological environment for DC maturation, some investigators advocate the utilization of balanced cocktails of maturation agents that may be the most representative of various inXammatory states [68] . At a cellular level, a cocktail of agents leads to the activation of several downstream pathways, and the consequent expression proWle could diVer from the simple sum of proWles of the genes induced by each single agent because of synergistic or antagonistic eVects. The Wrst and most frequently used cocktail contains TNF-, IL-1 , IL-6, and PGE2. The rationale for the use of this cocktail is to enhance the pro-inXammatory eVects of TNF-by adding other pre-inXammatory cytokines in an attempt to mimic the inXammatory environment that physiologically leads to the maturation of DCs. It's interesting to note that, although LPS can by itself induce the production and secretion of these same cytokines, gene expression proWles of DCs matured with LPS diVer markedly from that of DCs matured with the cocktail. Like TNF-alone, this cocktail leads to the induction of CCL17, CXCR4, and IL13R, but not IL10R and GM-CSFR [15] . Interestingly the expression of IL-6 is enhanced. IL-6 is a potent, pleiotropic, inXammatory cytokine that mediates a plethora of physiological functions, including the developmental diVerentiation of lymphocytes, cell proliferation, and cell survival [69] . Since IL-6 is biologically active only on cells that express constitutively IL-6R (B cells and hepatocytes), it is likely that it acts through transignaling in which IL-6 dimerizes with the soluble IL-6R shed by activated neutrophils and/or monocytes. However, this needs to be further explored in the context of DC activation. Other genes found to be increased by this cocktail are NF-kB1/2, CXCL-2/GRO-, TNFAIP3/6, CXCL-8/IL-8, CXCL-16, CD58, IL-2R, IL-7R, CRIP1, ISG20, BCL2A1, IER3, CFLAR, NCK2, and RUNX3 [15] . The functions of these genes are associated with inXammatory response and apoptosis. In vitro assays have clearly shown that DCs matured with this cocktail strongly stimulate the proliferation of allogeneic lymphocytes [70, 71] .
Although PGE2 is believed to play an important role in DC migration and lymph node homing, it is also considered responsible for some immune inhibitory properties of DCs [13] . In particular, the induction of indoleamine-2,3-deoxygenase (IDO), the increased secretion of IL-10 and the diminished secretion of IL-12 suggest that PGE2 may induce a tolerogenic immune response [15, 68, 72] . Additionally, several clinical studies have shown that plasma from patients with metastatic melanoma or renal cell carcinoma treated with DCs matured with this cocktail contain a mixture of Th1/Th2 cytokines, without resulting in a shifting toward a Th1-cytokines proWle [73] [74] [75] . For these reasons, several groups use cocktails of cytokine that do not contain PGE2.
One of these alternative cocktails contains IL-1 , TNF-, IFN-, IFN-, and poly (I:C). This maturation protocol seems to bias the maturation of DCs toward a Th1 phenotype since IL-12p40, IL-1 / , IL-2R / / , IL-6, CXCL-8/ IL-8, IL-15, CXCL-9/MIG, CXCL-10/IP10, and CXCL-11 are expressed at much higher levels compared with the PGE2-containing protocols [15] . Only the protocol containing poly (I:C) upregulates CCL4/MIP-1 , CCL5/RANTES, CCL20/MIP-3 , and CXCL-2/GRO , but CCL17/TARC and CXCL16 are not induced by the poly (I:C) containing protocol [15] . However, this cocktail of cytokines also induces the expression of functionally active IDO [15] , and it has been shown that the presence of poly(I:C) could aVect the antigen expression ability of DCs [76] . In vitro stimulation of autologous T cells by poly (I:C) matured DCs, in fact, failed to show a clear improvement respect to the stimulation of PGE2-matured DCs [15] .
Another of the PGE2-free maturation protocols contains LPS and IFN- [17] . Gene expression analysis of DCs matured under these conditions clearly demonstrates the expression of several chemokines, proinXammatory cytokines, and inXammatory-related genes. The expression of CCL2, CCL3, CCL4, CCL5, CCL8, CXCL-9, CXCL-10, CXCL-11, IL-1, IL-6, IL-8, IL-10, IL-12, TNF, DUSP5, and SOD2 were increased after 24 h, and these factors were found in the supernatants of DCs cultured with LPS and IFN-, indicating a strong Th1 polarization potential [17] . In vitro assays have shown that DCs matured with LPS and IFN-induce the stimulation of antigen-speciWc CD4 + and CD8 + T cells much more than PGE2-matured DCs [77] . These data suggest that a cocktail of cytokines induces factors that predominantly could be anticipated from the eVects of the individual cytokines with dominance by IFNdependent activation when either type I or type II IFNs or TLR agonists are added to the mixture, resulting in the induction of Th1 cells and eVector T-cell expansion [15] .
Conclusion: understanding and developing Th-polarized immune responses
Although gene expression proWling does not provide conclusive information about cell function, it does indicate predominant signaling pathways induced by a deWned state of stimuli. This review, which addressed the transcriptional activation of DCs upon various maturation stimuli, indicates that maturation protocols can be categorized according to target pathways and presumed eVects on cell function (Table 2) . Furthermore, because of the lack of comprehensive comparison studies on diVerent DCs maturation protocols, this review addresses important concepts concerning the diVerences of maturation protocols. In fact, by looking at the downstream pathways, we have categorized the diVerent protocols and have shown that some lead to similar expression patterns. Then, focusing on the most consistent data, we delineated the potential of DCs matured according to each protocol, showing the in vitro assay results that support the phenotype described by gene proWling. However, the ultimate comparison of protocols involves cellular assays and/or biomarkers associated with clinical outcomes. We, however, can speculate that gene expression proWling could identify biomarkers useful for quality control of DCs during manufacture and for potency evaluation of cellular products.
Although antigen-speciWc immunotherapy holds promise as an approach to cancer therapy, from a practical standpoint, limited, if any, clinical beneWts have been achieved for several possible reasons [9, 78] . None the less, it is likely that the function of DCs as antigen-presenting cells may play a central role, at least in the aVerent phase, in the induction of adaptive immune responses. DCs, in particular, have attracted much attention because of their primary role in presenting antigens to lymphocytes and simultaneously contributing to the recruitment and activation of various immune cells through cell-to-cell contact or through secretion of soluble factors.
Fifteen years after the Wrst studies of DC generation from monocytes, several diVerent protocols have been described to diVerentiate DCs from circulating mononuclear cells and to mature them into eYcient antigen-presenting units [8] , but only a few have been widely tested in clinical trials [9] . Consequently, it still remains questionable which DC maturation protocol provides the best cellular products for in vitro activation of adaptive immune responses or the adoptive transfer of antigen-loaded DCs.
The Wrst maturation protocols used clinically were based on a single compound and lead to a phenotypical complete maturation of DCs but not to a functional DC. For a long time, the cocktail containing TNF-, PGE2, IL-6, and IL-1 was considered the gold standard maturation protocol because it increased the ability of DCs to home in lymph nodes and recruit T cells. However, recent studies have shown that DCs matured with this protocol enhance the recruitment and activation of CCR4-expressing T regulatory cells by secreting CCL22/MDC [13, 79] and display a reduced ability to secrete active IL-12, which is thought to be fundamental for the induction of a Th1 immune response. Thus, diVerent groups are testing in clinical trials maturation protocols that contain IFNs since it appears that these cytokines are more directly linked and are likely essential for the induction of an eVector immune response [63] . Indeed, gene expression proWling [15] as well as other experimental evidence suggests that the maturation of DCs in the presence of IFNs seems to lead to a more powerful Th1-polarized immune response [7] .
Our analysis came to these same conclusions, but only by considering the most consistent genes induced by each maturation compound we did reveal several diVerences in DCs matured by diVerent protocols. According to our analysis, TNF-and CD40L-based maturation protocols shift the polarization of DCs toward a Th2 response; whereas IFNs-based protocols seem to be more able in activating Th1 cells. Moreover, our analysis suggested that the use of a cocktail of cytokines could lead to a more complete activation of DCs, better mimicking the one that occurs naturally in vivo where a combination of danger signals mature DCs. Among the cocktails of cytokines used, the potential of LPS in attracting diVerent immune cells could be the best utilized when combined with the Th1 activating power of IFN-.
Further studies are necessary to deWne the best way to diVerentiate, mature, and use DCs in order to obtain an eVective Th1 immunogenic response or a Th2 tolerogenic response. Moreover, although some antigen processing and presentation-related genes have been observed to be induced by maturation protocols [12] , it is still not clear how speciWc maturation protocols aVect antigen presentation. Antigen cross-presentation has been shown to be aVected by maturation stimulus [80] , but a comprehensive comparison of diVerent protocols is lacking.
DC activation of T cells can be used as a marker of the co-presence of an activating environment and antigen presentation. In recent years, several lines of evidence have indicated that during in vivo maturation DCs secrete a welldeWned cascade of cytokines [25] . These waves of cytokine production synergistically attract diVerent immune cells in a time-dependent fashion triggering a logical and systematic activation of the immune response which evolves from the early induction of innate eVector mechanisms to the subsequent expansion of eVector adaptive immune responses and, in the end, the induction of regulatory mechanisms aimed at limiting and eventually concluding the host's reaction to the pathogenic stimulus. While this physiological cascade is probably determined in vivo by a distinct group of maturing factors during the various phases of the immune response, the artiWcial over-exposure to higher than physiological doses of the same factors in the context of cellular therapy may eVectively bias the natural behavior of DCs toward one or the other outcomes of the immune response.
The lack of comprehensive comparisons among protocols and the time-dependent eVect of IFNs on DCs discussed before [25] shed light on the importance of deWning and comparing protocols currently used for DC maturation in the clinical arena. It is likely that DCs are not only aVected by the compounds/cocktail used, but also by the timing of their application in relation to the utilization of the DCs. In fact, several studies described a loss of DCs' activating power after they gained full maturation that was associated with reduced IL-12 secretion [11] , absence of DCs response to further stimulation [81, 82] , and impaired ability in inducing T cells activation [11] . Perhaps, by using the optimal timing and maturation protocol combination, it will be possible to obtain mature DCs that mimic physiological maturation and activate an eVective immune response.
